Phenol

Phenol

SCHEMBL22345138

C/C=C1/[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C(C(=O)OC)[C@H]1CC(O)OCCc1ccc(O)c(O)c1.Oc1ccccc1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.71
IL2 P60568 1/20 0.60
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
PPARG P37231 2/20 0.40
PPARD Q03181 2/20 0.40
PPARA Q07869 2/20 0.40
PRKCA P17252 3/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
STAT3 P40763 5/20 0.39
SLC5A1 P13866 1/20 0.39
SLC5A2 P31639 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL124603 0.96 BACE1 (0.77) BACE1IL2POLBKDM4EGAA
SCHEMBL7631773 0.96 BACE1 (0.77) BACE1IL2POLBKDM4EGAA
SCHEMBL124604 0.96 BACE1 (0.77) BACE1IL2POLBKDM4EGAA
SCHEMBL22400844 0.87 BACE1 (0.64) BACE1IL2POLBKDM4EGAA
Allicin SCHEMBL5451006 0.86 BACE1 (0.63) BACE1IL2POLBKDM4EGAA
Honokiol SCHEMBL3837036 0.86 BACE1 (0.62) BACE1IL2POLBKDM4EGAA
Oleuropein SCHEMBL23559534 0.83 BACE1 (1.00) BACE1IL2POLBKDM4EGAA
Oleuropein SCHEMBL24452037 0.83 BACE1 (1.00) BACE1IL2POLBKDM4EGAA
Oleuropein SCHEMBL21481089 0.83 BACE1 (1.00) BACE1IL2POLBKDM4EGAA
Oleuropein SCHEMBL23133255 0.83 BACE1 (1.00) BACE1IL2POLBKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220125869-A1 METHOD FOR OBTAINING OLEOCANTHAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS Omphax SA (GR) 2022-04-28 US disclosed
US-20220125869-A1 METHOD FOR OBTAINING OLEOCANTHAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS Omphax SA (GR) 2022-04-28 US disclosed
EP-3924081-A2 METHOD FOR OBTAINING OLEOCANTHAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS Omphax SA (GR) 2021-12-22 EP disclosed
EP-3924081-A2 METHOD FOR OBTAINING OLEOCANTHAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS Omphax SA (GR) 2021-12-22 EP disclosed
WO-2020165614-A9 METHOD FOR OBTAINING OLEOCANTHAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS MAGIATIS PROKOPIOS (GR) 2020-12-24 WO disclosed
WO-2020165614-A3 METHOD FOR OBTAINING OLEOCANTHAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS MAGIATIS PROKOPIOS (GR) 2020-09-24 WO disclosed
WO-2020165614-A2 METHOD FOR OBTAINING OLEOCANTHAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS MAGIATIS PROKOPIOS (GR) 2020-08-20 WO disclosed
WO-2020165614-A2 METHOD FOR OBTAINING OLEOCANTHAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS MAGIATIS PROKOPIOS (GR) 2020-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220125869-A1 METHOD FOR OBTAINING OLEOCANTHAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS CYP46A1, LIPA, SQLE BACE1 252/4885IL2 1322/4885POLB 2188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.